Filing Details

Accession Number:
0001209191-10-051749
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-10-26 21:22:01
Reporting Period:
2010-10-07
Filing Date:
2010-10-26
Accepted Time:
2010-10-26 20:22:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1124608 Response Genetics Inc RGDX In Vitro & In Vivo Diagnostic Substances (2835) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1346543 Becker Drapkin Management, L.p. 300 Crescent Court, Suite 1111
Dallas TX 75201
No No Yes No
1349003 Bc Advisors Llc 300 Crescent Court, Suite 1111
Dallas TX 75201
No No Yes No
1349005 R Steven Becker 300 Crescent Court, Suite 1111
Dallas TX 75201
No No Yes No
1451721 Becker Drapkin Partners, L.p. 300 Crescent Court, Suite 1111
Dallas TX 75201
No No Yes No
1451722 Becker Drapkin Partners (Qp), L.p. 300 Crescent Court, Suite 1111
Dallas TX 75201
No No Yes No
1458693 A Matthew Drapkin 300 Crescent Court, Suite 1111
Dallas TX 75201
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2010-10-07 46,102 $2.37 1,351,570 No 4 S Indirect See Footnotes
Common Stock Disposition 2010-10-07 5,698 $2.37 167,048 No 4 S Indirect See Footnotes
Common Stock Disposition 2010-10-08 22,250 $2.37 1,329,320 No 4 S Indirect See Footnotes
Common Stock Disposition 2010-10-08 2,750 $2.37 164,298 No 4 S Indirect See Footnotes
Common Stock Disposition 2010-10-13 44,500 $2.30 1,284,820 No 4 S Indirect See Footnotes
Common Stock Disposition 2010-10-13 5,500 $2.30 158,798 No 4 S Indirect See Footnotes
Common Stock Disposition 2010-10-22 87,285 $2.30 1,197,535 No 4 S Indirect See Footnotes
Common Stock Disposition 2010-10-22 12,715 $2.30 146,083 No 4 S Indirect See Footnotes
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Footnotes
No 4 S Indirect See Footnotes
No 4 S Indirect See Footnotes
No 4 S Indirect See Footnotes
No 4 S Indirect See Footnotes
No 4 S Indirect See Footnotes
No 4 S Indirect See Footnotes
No 4 S Indirect See Footnotes
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 381,679 Direct
Common Stock 114,504 Direct
Footnotes
  1. This statement is jointly filed by and on behalf of each of Becker Drapkin Management, L.P. ("BD Management"), Becker Drapkin Partners (QP), L.P., ("QP Fund"), Becker Drapkin Partners, L.P. ("LP Fund"), BC Advisors, LLC ("BC Advisors"), Steven R. Becker and Matthew A. Drapkin. QP Fund, LP Fund, Mr. Becker and Mr. Drapkin are the direct beneficial owners of the securities covered by this statement. BD Management is the general partner of each of QP Fund and LP Fund and may be deemed to beneficially own securities owned by QP Fund and LP Fund. BC Advisors is the general partner of BD Management and may be deemed to beneficially own securities owned by BD Management. Mr. Becker and Mr. Drapkin are the controlling persons of BC Advisors and may be deemed to beneficially own securities owned by BC Advisors.
  2. Each reporting person states that neither the filing of this statement nor anything herein shall be deemed an admission that such person is, for purposes of Section 16 of the Securities Exchange Act of 1934 (the "Act") or otherwise, the beneficial owner of any securities covered by this statement. Each reporting person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of such person in such securities.
  3. Each reporting person may be deemed to be a member of a group with respect to the issuer or securities of the issuer for purposes of Section 13(d) or 13(g) of the Act. Each reporting person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section 13(d) or 13(g) of the Act or any other purpose, a member of a group with respect to the issuer or securities of the issuer.
  4. Represents shares directly beneficially owned by QP Fund.
  5. Represents shares directly beneficially owned by LP Fund.
  6. Represents shares directly beneficially owned by Mr. Becker.
  7. Represents shares directly beneficially owned by Mr. Drapkin.